[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fn3TbqGTgzJMKeRk99n0xRVxXgCxil8eBPnM_DioH9bs":3},{"_id":4,"category":5,"content":9,"date":10,"heroImage":9,"newsPageBuilder":11,"seo":9,"slug":59,"title":60},"18cd2f76-e3e3-473c-845a-a09de075366b",{"_id":6,"slug":7,"title":8},"c098646c-9061-4278-96a9-6a3e9a140b5a","events","Events",null,"2024-05-06T00:00:00.000Z",[12],{"_key":13,"_type":14,"content":15},"nc3","newsContent",[16,27,35,43,51],{"_key":17,"_type":18,"children":19,"markDefs":25,"style":26},"b3p1","block",[20],{"_key":21,"_type":22,"marks":23,"text":24},"s3p1","span",[],"KLISBio, a regenerative medicine company utilizing silk-based technology, will participate in the European Federation of Societies for Microsurgery Congress from May 9-11, 2024. The company will operate booth #5 to showcase advances in peripheral nerve repair.",[],"normal",{"_key":28,"_type":18,"children":29,"markDefs":34,"style":26},"b3p2",[30],{"_key":31,"_type":22,"marks":32,"text":33},"s3p2",[],"Leadership including CEO Gabriele Grecchi and CTO Antonio Alessandrino will present the SILKBridge® Nerve Guide, described as the most advanced product in KLISBio's pipeline. The device remains pending regulatory clearance in the US, EU, and other regions.",[],{"_key":36,"_type":18,"children":37,"markDefs":42,"style":26},"b3p3",[38],{"_key":39,"_type":22,"marks":40,"text":41},"s3p3",[],"During the event, Prof. Maurizio Calcagni will present long-term follow-up results from SILKBridge® research. The device features a patented three-layer structure combining silk fibers with electrospun layers designed to promote cell adhesion while offering mechanical strength.",[],{"_key":44,"_type":18,"children":45,"markDefs":50,"style":26},"b3p4",[46],{"_key":47,"_type":22,"marks":48,"text":49},"s3p4",[],"Alessandrino stated that results from preliminary human trials mark a significant milestone, supporting plans for a pivotal clinical trial in 2025. Grecchi emphasized the company's commitment to securing CE Mark approval through comprehensive EU clinical studies while developing additional product sizes.",[],{"_key":52,"_type":18,"children":53,"markDefs":58,"style":26},"b3p5",[54],{"_key":55,"_type":22,"marks":56,"text":57},"s3p5",[],"KLISBio, headquartered in Milan, develops regenerative medicine platforms based on natural silk fibroin. The pipeline includes vascular grafts, bone graft substitutes, and rotator cuff repair solutions.",[],"klisbio-exhibit-2024-european-federation-societies-microsurgery-efsm-congress-milan","KLISBio to exhibit at 2024 European Federation of Societies for Microsurgery (EFSM) Congress in Milan"]